APA

Furuse K., Kubota K., Kawahara M., Ogawara M., Kinuwaki E., Motomiya M., Nishiwaki Y., Niitani H. & Sakuma A. (19950505). A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group. : Lung cancer (Amsterdam, Netherlands).

Chicago

Furuse K, Kubota K, Kawahara M, Ogawara M, Kinuwaki E, Motomiya M, Nishiwaki Y, Niitani H and Sakuma A. 19950505. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group. : Lung cancer (Amsterdam, Netherlands).

Harvard

Furuse K., Kubota K., Kawahara M., Ogawara M., Kinuwaki E., Motomiya M., Nishiwaki Y., Niitani H. and Sakuma A. (19950505). A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group. : Lung cancer (Amsterdam, Netherlands).

MLA

Furuse K, Kubota K, Kawahara M, Ogawara M, Kinuwaki E, Motomiya M, Nishiwaki Y, Niitani H and Sakuma A. A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group. : Lung cancer (Amsterdam, Netherlands). 19950505.